Cargando…

Chemotherapy of Capecitabine plus Temozolomide for Refractory Pituitary Adenoma after Tumor Resection and Its Impact on Serum Prolactin, IGF-1, and Growth Hormone

OBJECTIVE: To investigate the efficiency of capecitabine (CAP) plus temozolomide (TEM) in refractory pituitary adenoma after tumor resection and its impact on serum prolactin (PRL), insulin-like growth factor 1 (IGF-1), and growth hormone (GH) levels. METHODS: From January 2017 to January 2020, 80 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xirui, Hu, Changwei, Li, Yabin, Ren, Baowen, Yin, Gangfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959954/ https://www.ncbi.nlm.nih.gov/pubmed/35356252 http://dx.doi.org/10.1155/2022/8361775

Ejemplares similares

Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas with Adjuvant Temozolomide Chemotherapy: A Review
por: Moisi, Marc, et al.
Publicado: (2016)

An Aggressive Plurihormonal Pituitary Adenoma With Thyrotropin, Growth Hormone, and Prolactin Excess
por: Goh, QingCi, et al.
Publicado: (2023)

Synchronous GH- and prolactin-secreting pituitary adenomas
por: Rahman, Maryam, et al.
Publicado: (2014)

Temozolomide in aggressive pituitary adenomas and carcinomas
por: Ortiz, Leon D., et al.
Publicado: (2012)

Transformation of a Microprolactinoma into a Mixed Growth Hormone and Prolactin-Secreting Pituitary Adenoma
por: Dessimoz, Cédric, et al.
Publicado: (2012)

Glucose Abnormalities Associated to Prolactin Secreting Pituitary Adenomas
por: Auriemma, Renata S., et al.
Publicado: (2019)

Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review
por: Dai, Congxin, et al.
Publicado: (2021)

The Treatment of Refractory Pituitary Adenomas
por: Dai, Congxin, et al.
Publicado: (2019)

MON-406 Two Cases of Aggressive Corticotroph Pituitary Tumors Treated with Capecitabine and Temozolomide
por: Tateno, Tae, et al.
Publicado: (2019)

TSH, GH, and Prolactin Producing Pituitary Adenoma: An Unusual Case Presentation
por: Manrique, Helard Andres, et al.
Publicado: (2021)

PMON129 Pituitary Adenoma Co-Secreting GH, Prolactin and ACTH
por: Wilson, Sarah, et al.
Publicado: (2022)

PMON106 Persistent Prolactin Levels in a Patient with Pituitary Adenoma
por: Kadakia, Natasha, et al.
Publicado: (2022)

General seizures revealing macro-adenomas secreting prolactin or prolactin and growth hormone in men
por: Chentli, Farida, et al.
Publicado: (2014)

Temozolomide and Capecitabine Treatment for an Aggressive Somatotroph Pituitary Tumor: A Case Report and Literature Review
por: Ishida, Atsushi, et al.
Publicado: (2022)

The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
por: Dai, Congxin, et al.
Publicado: (2020)

Prolactin Variants in Human Pituitaries and Pituitary Adenomas Identified With Two-Dimensional Gel Electrophoresis and Mass Spectrometry
por: Qian, Shehua, et al.
Publicado: (2018)

Patient-reported outcomes in refractory hormone-producing pituitary adenomas: an unmet need
por: van Trigt, Victoria R., et al.
Publicado: (2023)

MON-304 Prolactin as a Surrogate Marker to Predict Long Term Postoperative Hypopituitarism After Transsphenoidal Resection of Pituitary Adenomas
por: German, Massiell, et al.
Publicado: (2020)

SAT-LB081 Growth Hormone and Prolactin Secreting Plurihormonal Pituitary Adenomas, Experience of a National Health Institute in Mexico
por: Guzmán-Pérez, Alberto, et al.
Publicado: (2019)

Refractory pituitary adenoma: a novel classification for pituitary tumors
por: Dai, Congxin, et al.
Publicado: (2016)

A novel “total pituitary hormone index” as an indicator of postoperative pituitary function in patients undergoing resection of pituitary adenomas
por: Wang, Shousen, et al.
Publicado: (2017)

Prolactin-producing pituitary adenoma with atypical spindle cell morphology: a case report
por: Inoue, Ritsurou, et al.
Publicado: (2015)

SUN-272 Significant Response to Temozolomide in Two Aggressively Growing Pituitary Adenomas
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2020)

Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas
por: Das, Liza, et al.
Publicado: (2021)

Relapse in pituitary adenoma after resection
por: Rochmah, Nur, et al.
Publicado: (2013)

Endoscopic resection of supergiant pituitary adenoma
por: Penner, Federica, et al.
Publicado: (2021)

Novel imaging techniques in refractory pituitary adenomas
por: MacFarlane, J, et al.
Publicado: (2023)

Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown Primary
por: Chauhan, Aman, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease with prolactin-secreting pituitary adenoma in an adolescent: A case report
por: Takaki, Yugo, et al.
Publicado: (2018)

PMON109 A Case of Non-functioning Pituitary Adenoma With Unexpectedly High Prolactin Level
por: Mahali, Lakshmi Priyanka, et al.
Publicado: (2022)

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report
por: Mirallas, Oriol, et al.
Publicado: (2021)

Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
por: Dai, Congxin, et al.
Publicado: (2021)

Isotocin Regulates Growth Hormone but Not Prolactin Release From the Pituitary of Ricefield Eels
por: Yang, Wei, et al.
Publicado: (2018)

Pituitary Actions of EGF on Gonadotropins, Growth Hormone, Prolactin and Somatolactins in Grass Carp
por: Hu, Qiongyao, et al.
Publicado: (2020)

What is the optimal prolactin cutoff for predicting the presence of a pituitary adenoma in patients with polycystic ovary syndrome?
por: Kim, Sang Il, et al.
Publicado: (2023)

Hormonal regulation of prolactin storage in a clonal strain of rat pituitary tumor cells.
por: Kiino, D. R., et al.
Publicado: (1982)

Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments
por: Wang, Renzhi, et al.
Publicado: (2022)

Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients
por: Ceccato, Filippo, et al.
Publicado: (2021)

Change in Character of Headache in a Young Female Patient With Prolactin Secreting Pituitary Adenoma Complicated With Mild Hemorrhage
por: Soe, Yuzana Myint, et al.
Publicado: (2021)

Extracapsular Resection of Pituitary Adenomas: A Systematic Review
por: Seng, Kenny S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dnooasvlkst951sil9jb6uk1ev